Results 51 to 60 of about 55,554 (173)

Bone Disorders in Pediatric Chronic Kidney Disease: A Literature Review

open access: yesBiology, 2023
Intense changes in mineral and bone metabolism are frequent in chronic kidney disease (CKD) and represent an important cause of morbidity and reduced quality of life. These disorders have conventionally been defined as renal osteodystrophy and classified
Lavinia Capossela   +7 more
doaj   +1 more source

The Role of Bone Biopsy in the Management of CKD-MBD

open access: yesCalcified Tissue International, 2021
A bone biopsy is still considered the gold standard for diagnosis of renal osteodystrophy. It allows to measure both static and dynamic parameters of bone remodeling and is the only method able to evaluate mineralization and allows analysis of both cortical and trabecular bone.
Ana Carina Ferreira   +3 more
openaire   +4 more sources

Metabolomics in Chronic Kidney Disease: The Emerging Role in Detection and Diagnosis of Mineral and Bone Disorders

open access: yesJournal of Health Science and Medical Research (JHSMR)
Chronic kidney disease (CKD) affects over 10% of the global population and is increasingly prevalent, placing a substantial strain on healthcare systems.
Salbiah Isa   +4 more
doaj   +1 more source

Association between proteinuria and mineral metabolism disorders in chronic kidney disease: the Japan chronic kidney disease database extension (J-CKD-DB-Ex)

open access: yesScientific Reports
Chronic kidney disease-mineral and bone disorder (CKD-MBD) are recognized as a systemic disease affecting the prognosis of patients with CKD. Proper management of CKD-MBD is important to improve the prognosis of patients with CKD. Although proteinuria is
Sho Shimamoto   +19 more
doaj   +1 more source

Augmented Fibroblast Growth Factor-23 Secretion in Bone Locally Contributes to Impaired Bone Mineralization in Chronic Kidney Disease in Mice

open access: yesFrontiers in Endocrinology, 2018
Chronic kidney disease-mineral and bone disorder (CKD-MBD) is a systemic disorder of mineral and bone metabolism caused by CKD. Impaired bone mineralization together with increased bony secretion of fibroblast growth factor-23 (FGF23) are hallmarks of ...
Olena Andrukhova   +4 more
doaj   +1 more source

Age-dependent parathormone levels and different CKD-MBD treatment practices of dialysis patients in Hungary - results from a nationwide clinical audit [PDF]

open access: yes, 2013
BACKGROUND: Achieving target levels of laboratory parameters of bone and mineral metabolism in chronic kidney disease (CKD) patients is important but also difficult in those living with end-stage kidney disease.
Túri, Sándor   +35 more
core   +1 more source

CKD-MBD - A [PDF]

open access: yesNephrology Dialysis Transplantation, 2013
K. Stevens   +37 more
openaire   +3 more sources

Association between serum phosphate levels and anemia in non-dialysis patients with chronic kidney disease: a retrospective cross-sectional study from the Fuji City CKD Network

open access: yesBMC Nephrology, 2023
Background Patients with chronic kidney disease (CKD) present high mortality and morbidity rates despite the availability of various therapies. Although CKD-mineral and bone disorder (MBD) and renal anemia are important factors in patients with CKD, only
Kazuhiko Kato   +4 more
doaj   +1 more source

CKD-MBD after kidney transplantation

open access: yesPediatric Nephrology, 2011
Successful kidney transplantation corrects many of the metabolic abnormalities associated with chronic kidney disease (CKD); however, skeletal and cardiovascular morbidity remain prevalent in pediatric kidney transplant recipients and current recommendations from the Kidney Disease Improving Global Outcomes (KDIGO) working group suggest that bone ...
Wesseling-Perry, Katherine   +1 more
openaire   +2 more sources

Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study.

open access: yes, 2016
BACKGROUND: Knowledge about mineral bone disorder (MBD) management in non-dialysis chronic kidney disease (ND-CKD) patients is scarce, although essential to identifying areas for therapeutic improvement.
G. Meneghel   +38 more
core   +1 more source

Home - About - Disclaimer - Privacy